Cost-effectiveness analysis of triple test in second-trimester maternal serum screening for Down's syndrome: An experience from Taiwan with decreasing birth rate but increasing population of old pregnant women

Journal of Evaluation in Clinical Practice

Volumn 14, Issue 2, 2008, Pages 191-197

  Hwa, Hsiao Lin ^a,b   Yen, Ming Fang ^c   Lin, Chen Li ^d   Ko, Tsang Ming ^a   Hsieh, Fon Jou ^a   Chen, Tony Hsiu Hsi ^c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d Women's and Children's Hospital   (Taiwan)

Author keywords

Cost effectiveness; Down's syndrome; Maternal serum screening

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL;

ADULT; AMNIOCENTESIS; ARTICLE; BIRTH RATE; BLOOD ANALYSIS; COST EFFECTIVENESS ANALYSIS; DOWN SYNDROME; ESTRIOL BLOOD LEVEL; EXPERIENCE; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SECOND TRIMESTER PREGNANCY; SENSITIVITY ANALYSIS; TAIWAN;

ADULT; BIRTH RATE; COST-BENEFIT ANALYSIS; DOWN SYNDROME; FEMALE; HUMANS; MASS SCREENING; MODELS, STATISTICAL; PREGNANCY; PREGNANCY TRIMESTER, SECOND; SERUM; TAIWAN;

EID: 40449138358     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2007.00831.x     Document Type: Article

References (25)

1. Cuckle, H. S. Wald, N. J. (1984) Maternal serum alpha-fetoprotein measurement: a screening test for Down's syndrome. Lancet, 1, 926 929.
2. Bogart, M., Pandian, M. R. Jones, O. W. (1987) Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenatal Diagnosis, 7, 623 630.
3. Canick, J., Knight, G. J., Palomaki, G. E., Haddow, J. E., Cuckle, H. S. Wald, N. J. (1988) Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome. British Journal of Obstetrics and Gynaecology, 95, 330 333.
4. Van Lith, J. M., Pratt, J. J., Beekhuis, J. R. Mantingh, A. (1992) Second trimester maternal serum immumo-reactive inhibin as a marker for fetal Down's syndrome. Prenatal Diagnosis, 12, 801 806.
5. Wald, N. J., Kennard, A., Hackshaw, A. McGuire, A. (1997) Antenatal screening for Down's syndrome. Journal of Medical Screening, 4, 181 246.
6. Wang, Y. Y., Luo, J., Zhu, M. W., Liu, L. N. Ma, X. (2006) Second-trimester double or triple screening for Down syndrome: a comparison of Chinese and Caucasian populations. International Journal of Gynaecology and Obstetrics, 94, 67 72.
7. Swint, J. M. Greenberg, F. (1988) Maternal serum alpha-fetoprotein screening for Down syndrome: economic considerations. American Journal of Medical Genetics, 31, 231 245.
8. Gill, M., Murday, V. Slack, J. (1987) An economic appraisal of screening for Down's syndrome in pregnancy using maternal age and serum alpha fetoprotein concentration. Social Science and Medicine, 24, 725 731.
9. Seror, V., Muller, F., Moatti, J. P., Le Gales, C. Bone, A. (1993) Economic assessment of maternal serum screening of Down's syndrome using human chorionic gonadotropin. Prenatal Diagnosis, 13, 281 292.
10. Sheldon, T. A. Simpson, J. (1991) Appraisal of a new scheme for prenatal screening for Down's syndrome. British Medical Journal, 302, 1133 1136.
11. Shackley, P., McGuire, A., Boyd, P., Dennis, J., Fitchett, M., Kay, J., Roche, M. Wood, P. (1993) An economic appraisal of alternative prenatal screening programmes for Down's syndrome. Journal of Public Health Medicine, 15, 175 184.
12. Macri, J. N., Kasturi, R. V., Krantz, D. A., Cook, E. J., Sunderji, S. G. Larsen, J. W. (1990) Maternal serum Down syndrome screening: unconjugated estriol is not useful. American Journal of Obstetrics and Gynecology, 162, 672 673.
13. Ganiats TG, Halverson AL, Bogart MH. (1994) Incremental cost-effectiveness of incorporating oestriol evaluation in Down's syndrome screening programmes. Prenatal Diagnosis, 14, 527 535.
14. Gilbert, R. E., Gupta, A. R., Ades, A. E., Logan, S., Sculpher, M. van der Meulen, J. H. P. (2001) Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies. British Medical Journal, 323, 1 6.
15. Torgerson, D. J. (1996) The impact of maternal age on the cost-effectiveness of Down's syndrome screening. British Journal of Obstetrics and Gynaecology, 103, 581 583.
16. Lin, S. J. (1994) Down's syndrome. Acta Paediatrica Sinica, 35A, 28 31.
17. Hook, E. B. (1978) Spontaneous deaths of fetuses with chromosome abnormalities diagnosed prenatally. New England Journal of Medicine, 299, 1036 1038.
18. Ko, T. M., Lee, T. Y., Yu, T. K. Chuang, S. M. (1983) Prenatal diagnosis of Down's syndrome with maternal balanced 15p/21q translocation and paternal 47, XXY/ 46, XY mosaicism - a case report. Taiwanese Journal of Obstetrics and Gynecology, 22, 303 308.
19. Hsu, J. J., Hsieh, T. T. Hsieh, F. J. (1996) Down's syndrome screening in an Asian population using alpha-fetoprotein and free-beta hCG: a report of the Taiwan Down Syndrome Screening Group. Obstetrics and Gynecology, 87, 943 947.
20. Tabor, A., Madson, M., Obel, E. B., Philip, J., Bank, J. Norgaard-Pedersen, B. (1986) Randomized controlled trial of genetic amniocentesis in 40000 low risk women. Lancet, 1, 1287 1293.
21. Hanley, J. A. McNeil, B. J. (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology, 143, 29 36.
22. Kobelt, G. (1996) Health Economics - An Introduction to Economic Evaluation. London : Office of Health Economics.
23. Kellner, L. H., Weiner, Z., Weiss, R. R., Neuer, M., Martin, G. M., Mueenuddin, M. Bombard, A. (1995) Triple marker (alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha-fetoprotein plus free-beta subunit in second trimester maternal serum screening for fetal Down syndrome: a prospective comparison study. American Journal of Obstetrics and Gynecology, 173, 1306 1309.
24. Olsen, C. L., Cross, P. K. Gensberg, L. J. (2003) Down syndrome: interaction between culture, demography, and biology in determining the prevalence of a genetic trait. Human Biology, 75, 503 520.
25. Huang, T., Watt, H. C. Wald, N. J. (1997) The effect of differences in the distribution of maternal age in England and Wales on the performance of antenatal screening for Down's syndrome. Prenatal Diagnosis, 17, 615 621.